Ai Agent

Orchestra Bio • OpenAI

OpenAI acquires Orchestra Bio to build drug-development AI agents, terms undisclosed: OpenAI is acquiring Orchestra Bio and merging it with its life sciences AI platform Rosalind to build AI agents for drug development. The agents will help pharma teams coordinate drug development, from tracking trials to spotting problems. Financial terms were not disclosed.

C1.ai • acquisition

Workday agrees to acquire C1.ai, formerly ConductorOne, which has raised $111M: Workday has agreed to acquire C1.ai, formerly ConductorOne, which makes enterprise software for managing human and AI agent identities. C1.ai has raised $111M, according to Portland Business Journal.

RapidCanvas • Series B

RapidCanvas raises nearly $29M Series B to help businesses build custom AI tools: RapidCanvas raised nearly $29M in Series B funding led by Vertex Ventures and Hitachi Ventures, CEO Rahul Pangam tells Axios. The Austin-based company uses agents to help businesses build and deploy custom AI applications.

Opsin • Opsin

Opsin raises $21M to help companies monitor AI agent activity and data access: Opsin raised $21M in funding led by SYN Ventures and Race Capital. The company helps companies show where AI agents are active, what data they access, and flag risky behavior.